Watch Demo

South Korea Lipid Modifying Drug Industry Outlook 2022 - 2026

See how South Korea Lipid Modifying Drug performed compared to key markets such as Spain and Italy.

Key Market Indicators

Sales of lipid-modifying medicines in Korea are expected to hit $2 billion by 2026, up from $1.7 billion in 2021. This represents an average annual increase of 3%. Since 2013, the Korean market has grown annually by 10.5%. Spain, Italy and Germany are second, third and fourth in this ranking, respectively.

Marketing Banner

South Korea Lipid Modifying Drug Market Data and Forecasts

How much will South Korea Lipid Modifying Drug Market grow to 2026?

Forecast: Lipid Modifying Medicine Sales in South Korea
Forecast: Lipid Modifying Medicine Sales in South Korea
Forecast: Lipid Modifying Medicine Sales in South Korea
Forecast: Lipid Modifying Medicine Sales in South Korea
Forecast: Lipid Modifying Medicine Sales in South Korea
More in Lipid Modifying Drug Industry for 2028